How Evaluate Helps
Dealmaking is the lifeblood of the pharma industry but the path from a long list of potential partners to a successful deal is a long and complex one. Evaluate’s solutions provide the insight and support you need to navigate this path. From identifying strategic partnership opportunities, and streamlined due diligence to negotiation strategies and deal benchmarking.
Your BD&L objectives are core to your commercial success. By partnering with Evaluate, you can negotiate deals that drive return on investment and accelerate innovation.
Tailored support for your decision-making process
Our expert consultants partner with clients to address business questions throughout the BD&L process. They streamline decision-making to build commercially-focused pipelines and help address the balance between internal and external innovation, offering;
In-licensing candidate long list generation and prioritization
Out-licensing partner identification, prioritization and outreach
Asset valuation and due diligence
Innovation trends analysis
Pipeline tracking and competitor monitoring
Find out more about how our consultants can support your business development and portfolio strategy needs here.
Build a winning commercial strategy with Biomedtracker
Biomedtracker is your go-to platform for real-time analysis of commercial, clinical, and regulatory activities. With an easily searchable interface, automated alerts, and human insight you’ll always be one step ahead of the competition.
Our analysts provide context to major market events, detailing what happened, what’s next, and why it matters. Cut through the noise and gain a deeper understanding of the impact on your business with Biomedtracker.
Learn more about how Biomedtracker can provide market analysis to guide your commercial decisions.
